TherapeuticsMD, Inc. — Director's Dealing 2021

Aug 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2021-08-10

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-10	Common Stock	M	145296	—	Acquired	148851	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-10	Restricted Stock Units	$0	M	145296	Disposed		Common Stock (145596)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	704600	Indirect
Common Stock	1001	Indirect

Footnotes

F1: On August 10, 2021, the reporting person received 145,296 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021.

F2: The reported securities are owned by Thompson Family Investments, LLC, an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.

F3: The reported securities are owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.

F4: Each RSU represented a contingent right to receive one share of issuer common stock upon settlement.

F5: The RSUs fully vested on June 18, 2021.